#CLOBETASOL PROPIONATE SKIN#

Clobetasol propionate cream USP, 0.05% (emollient) is indicated for the topical treatment of moderate to severe plaque-type psoriasis.

Treatment should be limited to 2 consecutive weeks, and the total dosage should not exceed 50 grams per week. Clobetasol propionate cream USP, 0.05% (emollient) is indicated for the relief of the inflammatory and pruritic manifestations of cortico-steroid-responsive dermatoses in patients 12 years of age and older.

#CLOBETASOL PROPIONATE SKIN#

Common adverse reactions include pruritis, irritation, erythema, folliculitis, cracking and fissuring of the skin, numbness of the fingers, tenderness in the elbow, skin atrophy, and telangiectasia.Īdult Indications and Dosage FDA-Labeled Indications and Dosage (Adult) Corticosteroid-Responsive Dermatoses OverviewĬlobetasol propionate is a coticosteroid emollient that is FDA approved for the treatment of corticosteroid-responsive dermatoses in patients 12 years of age or older, severe plaque-type psoriasis in patients 16 years of age and older. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. Associate Editor(s)-in-Chief: Vignesh Ponnusamy, M.B.B.S.